Trust Stamp has announced a $3 million securities offering, including shares and warrants, expected to close on December 6, 2024.
Quiver AI Summary
Trust Stamp has announced a securities purchase agreement with an institutional investor for the sale of 5,555,548 shares of common stock in a registered direct offering, which will also include concurrent private placements of Series A and B Warrants. The total gross proceeds from this offering are estimated to be around $3 million. Each share and warrant will be offered at a combined price of $0.54, and the warrants will be exercisable following shareholder approval. The offering is set to close on December 6, 2024, and will be conducted under a previously effective registration statement with the SEC. Maxim Group LLC is the sole placement agent for the offering. The press release emphasizes that the securities cannot be sold in jurisdictions where such sales would be illegal prior to proper registration.
Potential Positives
- Trust Stamp has secured approximately $3.0 million in gross proceeds through a registered direct offering and a concurrent private placement, which could help fund its operations and growth initiatives.
- The issuance of Series A and Series B Warrants provides potential for additional capital raise through future exercises.
- The offering follows an effective shelf registration statement with the SEC, demonstrating compliance and readiness to access capital markets.
Potential Negatives
- The issuance of shares and warrants at a low effective combined offering price of $0.54 may signal a lack of investor confidence and could dilute existing shareholders' equity.
- The need for shareholder approval for the exercise of the Series A and Series B Warrants may create uncertainty regarding future fundraising and could lead to complications in governance.
- The offering is labeled as a private placement, which may indicate limited market interest and could hinder the company's ability to attract additional institutional investors in the future.
FAQ
What is Trust Stamp's recent securities purchase agreement?
Trust Stamp has entered a securities purchase agreement for 5,555,548 shares of common stock with an institutional investor.
What are Series A and Series B Warrants?
Series A and B Warrants are unregistered warrants that allow the purchase of common stock at an exercise price of $0.54.
What are the estimated gross proceeds from the offering?
The estimated gross proceeds from the offering are approximately $3.0 million before expenses.
When is the closing date for the offering?
The closing date for the offering is expected to be on or about December 6, 2024, subject to closing conditions.
Where can I find the prospectus for the offering?
Copies of the prospectus supplement will be filed with the SEC and available at www.sec.gov or through Maxim Group LLC.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$IDAI Insider Trading Activity
$IDAI insiders have traded $IDAI stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IDAI stock by insiders over the last 6 months:
- HOLDINGS INC. DQI purchased 1,363,636 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IDAI Hedge Fund Activity
We have seen 10 institutional investors add shares of $IDAI stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 589,917 shares (+inf%) to their portfolio in Q3 2024
- CITADEL ADVISORS LLC added 111,998 shares (+93.8%) to their portfolio in Q3 2024
- GEODE CAPITAL MANAGEMENT, LLC added 33,579 shares (+61.2%) to their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC added 17,000 shares (+inf%) to their portfolio in Q3 2024
- JANE STREET GROUP, LLC added 14,940 shares (+inf%) to their portfolio in Q3 2024
- HRT FINANCIAL LP added 13,165 shares (+inf%) to their portfolio in Q3 2024
- B. RILEY WEALTH ADVISORS, INC. removed 13,000 shares (-100.0%) from their portfolio in Q2 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Atlanta, GA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), a global provider of AI-powered technologies, today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,555,548 shares of common stock (or pre-funded warrants in lieu thereof) in a registered direct offering. In a concurrent private placement, the Company also agreed to issue and sell unregistered Series A Warrants to purchase up to an aggregate of 5,555,548 shares of common stock, and unregistered Series B Warrants to purchase up to an aggregate of 4,166,661 shares of common stock. The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and the accompanying Series A Warrants and Series B Warrants is $0.54. Each private placement warrant will be exercisable upon receipt of shareholder approval, will expire five years from the initial exercise date and will have an exercise price of $0.54 per share.
The combined gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $3.0 million before deducting the placement agent’s fees and other estimated offering expenses payable by the Company. The offering is expected to close on or about December 6, 2024, subject to the satisfaction of customary closing conditions.
Maxim Group LLC is acting as the sole placement agent in connection with the offering.
The shares of common stock (or pre-funded warrants in lieu thereof) are being offered pursuant to a shelf registration statement on Form S-3 (File No. 333-271091), which was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 12, 2023. The offering of shares of common stock (or pre-funded warrants in lieu thereof) will be made only by means of a prospectus supplement that forms a part of such registration statement. A prospectus supplement relating to the shares of common stock and prefunded warrants offered in the registered direct offering will be filed by the Company with the SEC. When available, copies of the prospectus supplement relating to the registered direct offering, together with the accompanying prospectus, can be obtained at the SEC's website at www.sec.gov or from Maxim Group LLC, 300 Park Avenue, New York, NY 10022, Attention: Syndicate Department, or via email at [email protected] or telephone at (212) 895-3500.
The Series A Warrants and Series B Warrants to be issued in the concurrent private placement and the shares issuable upon exercise of such warrants were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder and have not been registered under the Act or applicable state securities laws.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
About Trust Stamp
Trust Stamp, the Privacy-First Identity Company ™, is a global provider of AI-powered software and data transformation services for use in multiple sectors, including banking and finance, regulatory compliance, government, real estate, communications, and humanitarian services. Trust Stamp is located across North America, Europe, Asia, and Africa and trades on the Nasdaq Capital Market (Nasdaq: IDAI).
Forward-Looking Statements
All statements in this release that are not based on historical fact are “forward-looking statements,” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events .
Trust Stamp
Email:
[email protected]